Medicover (Germany) Market Value
5M0B Stock | EUR 15.14 0.16 1.05% |
Symbol | Medicover |
Medicover 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medicover's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medicover.
12/13/2022 |
| 12/02/2024 |
If you would invest 0.00 in Medicover on December 13, 2022 and sell it all today you would earn a total of 0.00 from holding Medicover AB or generate 0.0% return on investment in Medicover over 720 days. Medicover is related to or competes with Humana, Ramsay Gnrale, Superior Plus, Origin Agritech, Identiv, and INTUITIVE SURGICAL. Medicover AB provides diagnostic and healthcare services in Germany, Romania, Ukraine, Poland, Belarus, Moldova, Serbia,... More
Medicover Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medicover's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medicover AB upside and downside potential and time the market with a certain degree of confidence.
Information Ratio | (0.15) | |||
Maximum Drawdown | 6.34 | |||
Value At Risk | (1.86) | |||
Potential Upside | 2.37 |
Medicover Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medicover's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medicover's standard deviation. In reality, there are many statistical measures that can use Medicover historical prices to predict the future Medicover's volatility.Risk Adjusted Performance | (0.03) | |||
Jensen Alpha | (0.11) | |||
Total Risk Alpha | (0.31) | |||
Treynor Ratio | (0.29) |
Medicover AB Backtested Returns
Medicover AB has Sharpe Ratio of -0.0671, which conveys that the firm had a -0.0671% return per unit of risk over the last 3 months. Medicover exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Medicover's Standard Deviation of 1.38, risk adjusted performance of (0.03), and Mean Deviation of 1.06 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.26, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Medicover's returns are expected to increase less than the market. However, during the bear market, the loss of holding Medicover is expected to be smaller as well. At this point, Medicover AB has a negative expected return of -0.0912%. Please make sure to verify Medicover's coefficient of variation, jensen alpha, and the relationship between the mean deviation and standard deviation , to decide if Medicover AB performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.4 |
Poor reverse predictability
Medicover AB has poor reverse predictability. Overlapping area represents the amount of predictability between Medicover time series from 13th of December 2022 to 8th of December 2023 and 8th of December 2023 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medicover AB price movement. The serial correlation of -0.4 indicates that just about 40.0% of current Medicover price fluctuation can be explain by its past prices.
Correlation Coefficient | -0.4 | |
Spearman Rank Test | -0.4 | |
Residual Average | 0.0 | |
Price Variance | 3.79 |
Medicover AB lagged returns against current returns
Autocorrelation, which is Medicover stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Medicover's stock expected returns. We can calculate the autocorrelation of Medicover returns to help us make a trade decision. For example, suppose you find that Medicover has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Medicover regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Medicover stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Medicover stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Medicover stock over time.
Current vs Lagged Prices |
Timeline |
Medicover Lagged Returns
When evaluating Medicover's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Medicover stock have on its future price. Medicover autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Medicover autocorrelation shows the relationship between Medicover stock current value and its past values and can show if there is a momentum factor associated with investing in Medicover AB.
Regressed Prices |
Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Medicover Stock
Medicover financial ratios help investors to determine whether Medicover Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medicover with respect to the benefits of owning Medicover security.